Product NDC: | 0591-5325 |
Proprietary Name: | Probenecid and Colchicine |
Non Proprietary Name: | Probenecid and Colchicine |
Active Ingredient(s): | .5; 500 mg/1; mg/1 & nbsp; Probenecid and Colchicine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0591-5325 |
Labeler Name: | Watson Laboratories, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA084279 |
Marketing Category: | ANDA |
Start Marketing Date: | 19821001 |
Package NDC: | 0591-5325-01 |
Package Description: | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5325-01) |
NDC Code | 0591-5325-01 |
Proprietary Name | Probenecid and Colchicine |
Package Description | 100 TABLET in 1 BOTTLE, PLASTIC (0591-5325-01) |
Product NDC | 0591-5325 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Probenecid and Colchicine |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 19821001 |
Marketing Category Name | ANDA |
Labeler Name | Watson Laboratories, Inc. |
Substance Name | COLCHICINE; PROBENECID |
Strength Number | .5; 500 |
Strength Unit | mg/1; mg/1 |
Pharmaceutical Classes | Cytochrome P450 3A4 Inhibitors [MoA],P-Glycoprotein Interactions [MoA] |